Apr 22, 2021 — “We are excited to have the opportunity to present significant additional data from our Phase 2b study evaluating our investigational therapy ...
DOWNLOAD: https://byltly.com/2fa0pf
DOWNLOAD: https://byltly.com/2fa0pf
jcyte-phase-2b
jCyte, Inc. Collaborator: California Institute for Regenerative Medicine (CIRM) ... of acceptable safety and tolerability in a phase 1/2a study, this phase 2b study is .... Jul 27, 2020 — jCyte Inc. announced promising results from a phase 2b clinical trial of jCell in retinitis pigmentosa (RP), irrespective of genetic subtype. jCell is .... Phase 2b results show that treatment with jCell was well-tolerated and demonstrated encouraging evidence of potential benefit in patients as an investigational ... 939c2ea5af
Comments